Algert Global’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-17,945
| Closed | -$1.05M | – | 1321 |
|
|
2023
Q4 | $1.05M | Sell |
17,945
-56,341
| -76% | -$3.31M | 0.04% | 605 |
|
|
2023
Q3 | $3.24M | Buy |
74,286
+770
| +1% | +$33.5K | 0.15% | 212 |
|
|
2023
Q2 | $2.66M | Buy |
73,516
+10,292
| +16% | +$372K | 0.12% | 289 |
|
|
2023
Q1 | $2.35M | Buy |
63,224
+34,079
| +117% | +$1.27M | 0.11% | 288 |
|
|
2022
Q4 | $1.32M | Buy |
29,145
+9,540
| +49% | +$432K | 0.07% | 455 |
|
|
2022
Q3 | $1.37M | Buy |
19,605
+7,805
| +66% | +$545K | 0.08% | 415 |
|
|
2022
Q2 | $792K | Buy |
11,800
+417
| +4% | +$28K | 0.06% | 576 |
|
|
2022
Q1 | $936K | Buy |
11,383
+8,728
| +329% | +$718K | 0.06% | 554 |
|
|
2021
Q4 | $389K | Sell |
2,655
-1,730
| -39% | -$253K | 0.05% | 636 |
|
|
2021
Q3 | $776K | Buy |
4,385
+1,641
| +60% | +$290K | 0.1% | 352 |
|
|
2021
Q2 | $443K | Buy |
2,744
+371
| +16% | +$59.9K | 0.15% | 199 |
|
|
2021
Q1 | $406K | Buy |
+2,373
| New | +$406K | 0.13% | 245 |
|
|
2020
Q2 | – | Sell |
-7,174
| Closed | -$551K | – | 519 |
|
|
2020
Q1 | $551K | Buy |
+7,174
| New | +$551K | 0.23% | 158 |
|